These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 2543272)

  • 1. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.
    Monaghan DT; Bridges RJ; Cotman CW
    Annu Rev Pharmacol Toxicol; 1989; 29():365-402. PubMed ID: 2543272
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acid receptors and uptake systems in the mammalian central nervous system.
    Dingledine R; Boland LM; Chamberlin NL; Kawasaki K; Kleckner NW; Traynelis SF; Verdoorn TA
    Crit Rev Neurobiol; 1988; 4(1):1-96. PubMed ID: 2461808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spider toxins as tools for dissecting elements of excitatory amino acid transmission.
    Jackson H; Usherwood PN
    Trends Neurosci; 1988 Jun; 11(6):278-83. PubMed ID: 2465627
    [No Abstract]   [Full Text] [Related]  

  • 4. On the nature of the receptors for various excitatory amino acids in the mammalian central nervous system.
    McLennan H
    Adv Biochem Psychopharmacol; 1981; 27():253-62. PubMed ID: 6255760
    [No Abstract]   [Full Text] [Related]  

  • 5. Excitatory amino acid receptors in the vertebrate central nervous system.
    Collingridge GL; Lester RA
    Pharmacol Rev; 1989 Jun; 41(2):143-210. PubMed ID: 2558391
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endogenous factors of neurodestruction (the pharmacologic aspects)].
    Kozlovskiĭ VL
    Farmakol Toksikol; 1990; 53(5):7-13. PubMed ID: 2174797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of receptors for excitatory amino acids.
    Watkins JC; Davies J; Evans RH; Francis AA; Jones AW
    Adv Biochem Psychopharmacol; 1981; 27():263-73. PubMed ID: 6108694
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.
    McDonald JW; Johnston MV
    Brain Res Brain Res Rev; 1990; 15(1):41-70. PubMed ID: 2163714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GABA and drug effects on the central nervous system].
    Ledaal P
    Tidsskr Nor Laegeforen; 1982 Mar; 102(7):440-1. PubMed ID: 6297120
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral pharmacology of melatonin.
    Kulkarni SK; Shaji AV
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):237-47. PubMed ID: 9646286
    [No Abstract]   [Full Text] [Related]  

  • 11. On the molecular mechanism of adrenocorticotrophic hormone in the CNS: neurotransmitters and receptors.
    Pranzatelli MR
    Exp Neurol; 1994 Jan; 125(1):142-61. PubMed ID: 7905835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological pathways regulating neuromediator processes in the central nervous system during aging].
    Burchinskiĭ SG; Tordiia GD
    Farmakol Toksikol; 1986; 49(3):120-6. PubMed ID: 2873051
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormones of the central nervous system--phylogenetic and integrated approach].
    Langer P
    Vnitr Lek; 1989 Mar; 35(3):214-8. PubMed ID: 2567553
    [No Abstract]   [Full Text] [Related]  

  • 14. [The biochemical basis of pharmaceutical chemistry. 4. Modification of central neurobiochemical processes by drugs].
    Nuhn P
    Pharmazie; 1988 Aug; 43(8):565-76. PubMed ID: 2907146
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we conquer pain?
    Scholz J; Woolf CJ
    Nat Neurosci; 2002 Nov; 5 Suppl():1062-7. PubMed ID: 12403987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of pharmacological receptors in mammalian central nervous system.
    Banerjee PK; Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1989 Apr; 27(4):310-6. PubMed ID: 2553590
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurotoxicity of excitatory amino acids and the central nervous system].
    Martos JM; Expósito MJ; Saniger MA; Huerta JM
    Rev Clin Esp; 1996 Feb; 196(2):113-8. PubMed ID: 8685483
    [No Abstract]   [Full Text] [Related]  

  • 18. 3H-(3MeHis2)thyrotropin releasing hormone receptors in rat central nervous system.
    Simasko SM; Horita A
    Proc West Pharmacol Soc; 1982; 25():75-8. PubMed ID: 6289346
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterodimerization of G-protein-coupled receptors in the CNS.
    Marshall FH
    Curr Opin Pharmacol; 2001 Feb; 1(1):40-4. PubMed ID: 11712533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netrins: beyond the brain.
    Cirulli V; Yebra M
    Nat Rev Mol Cell Biol; 2007 Apr; 8(4):296-306. PubMed ID: 17356579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.